A two-drug combination for metastatic melanoma reduced the odds of progression by 60 percent, demonstrating more effectiveness than monotherapy, according to researchers.
Derm In The News: September 24-30
The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis
The Importance of Timing With Live Vaccinations in Pediatric Atopic Dermatitis
The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques
Discovering Dermatology Times: September 2023 BCC Management Supplement
Understanding Eyebrow and Eyelash Hair Loss in Severe Alopecia Areata
2 Clarke Drive Cranbury, NJ 08512